icon
icon
icon
icon
icon
icon
icon
icon
Close browser
icon
Go back to News
NEWS

GA_P advises A&G on its investment in Regeneraqua

icon 8 September, 2025

Gómez-Acebo & Pombo has advised A&G Sustainable Infrastructure on its investment in the company Regeneraqua, whose purpose is to promote, from the private sector, projects for the production and supply of reclaimed water from wastewater treatment plants.

The Firm also provides ongoing regulatory advice to society for the development of these projects, pioneers in the private sector, in accordance with the new regulatory framework established by the Water Reuse Regulation, approved by Royal Decree 1085/2020, a regulation that recognizes for the first time in our legal system the possibility for private operators to provide the service of producing and supplying reclaimed water to end users and charge for said services.

This operation constitutes an innovative initiative for the development of circular economy projects by the private sector in a sector heavily influenced by the government, such as the provision of water supply services.

The GA_P team was led by Estibaliz Aranburu and Irantzu Aguirre from the Corporate team; Rocío Arias and John Galilea from the Tax team; and Carlos Vázquez, Eduardo Orteu, and Fernando Trigo from the Public and Regulated Sectors team.

Lawyer mentioned

Estibaliz Aranburu – Partner

Irantzu Aguirre – Senior associate

See all lawyersicon
See less lawyersicon
Category

Deal

Areas and sectors

Public Law and Regulated Sectors

Corporate and M&A

Tax

Press contact

Sandra Cuesta
Sandra Cuesta
Director of Business Development, Marketing and Communications
email scuesta@ga-p.com
Madrid, (+34) 91 582 91 00
Sandra Cuesta
Sandra Cuesta
Director of Business Development, Marketing and Communications
email scuesta@ga-p.com
Madrid, (+34) 91 582 91 00
icon
icon

More information about
Gómez-Acebo & Pombo

News icon Publications icon
icon
icon
icon
icon
PUBLICATION
Pharma & Healthcare No. 45
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
icon 5 days ago
icon icon
PUBLICATION
The Unified Patent Court takes jurisdiction to hear a claim concerning the infringement of the UK national part of a European patent, even when the validity of the patent is being disputed
In a decision dated 18 July 2025, the Mannheim Division of the Court of First Instance of the Unified Patent Court took jurisdiction to hear a claim filed against three companies domiciled in Germany for infringement of a classic European patent with effect in Germany and the United Kingdom. The court's jurisdiction to hear the infringement of the UK national part of European patents is not affected by the fact that the validity of the patent is disputed by the defendants. However, this conclusion does not apply to Spanish national parts of European patents.
icon 15 Sep, 2025
icon icon
PUBLICATION
Property Transfer Tax in assignment of promissory contracts to sell real estate in Portugal
This article analyses situations which, although they do not involve the transfer of property ownership, are legally treated as equivalent to a sale and are subject to Transfer Tax in Portugal.
icon 02 Sep, 2025
icon icon
PUBLICATION
Automotive and Sustainable Mobility No. 27
Summary of legislative and jurisprudential developments relating to the automotive sector.
icon 05 Aug, 2025
icon icon
PUBLICATION
The Court of Justice upholds the annulment of the European Commission's third decision on the scheme for the tax amortisation of financial goodwill
La Sentencia del Tribunal de Justicia de 26 de junio del 2025 declara que las dos primeras decisiones de la Comisión Europea sobre la incompatibilidad con las normas sobre ayudas estatales del régimen de amortización fiscal del fondo de comercio financiero generaron confianza legítima sobre el alcance y límites de la obligación de recuperación, incluyendo dentro de su alcance las adquisiciones directas e indirectas de participaciones en empresas extranjeras. Por tanto, no cabe la recuperación retroactiva de las ayudas relacionadas con adquisiciones indirectas cubiertas por las dos primeras decisiones, por lo que debe procederse a su devolución junto con los intereses de demora.
icon 15 Jul, 2025
icon icon
PUBLICATION
Once again on the obligations assumed by the signers of a "strong" comfort letter
icon 09 Jul, 2025
icon icon
PUBLICATION
Pharma & Healthcare No. 44
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
icon 02 Jul, 2025
icon icon
PUBLICATION
Company resolutions reached with invalid votes
Although Article 204(3)(d) places them on the same level, the erroneous counting of votes and the counting of invalid votes are very different, given that the latter requires judicial balancing.
icon 19 Jun, 2025
icon icon
PUBLICATION
CJEU clarifies conditions under which EU law may prohibit national tax exemptions
For the Grand Chamber of the CJEU, a tax exemption based on objective and non-discriminatory criteria and integrated into the logic of the legal system which it accompanies is inherent in the ‘normal’ tax regime and does not, in principle, confer a selective advantage. In such cases, the conditions for granting the exemption are neutral from the point of view of competition, as the fact that some undertakings satisfy those conditions, while others do not, is not relevant in the light of the rules on State aid.
icon 22 May, 2025
icon icon